Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral error catastrophe by mutagenic nucleosides.

Jon P Anderson1, Richard Daifuku, Lawrence A Loeb

  • 1The Joseph Gottstein Memorial Cancer Research Laboratory, Department of Pathology, University of Washington, Seattle, Washington 98195, USA. jonand@u.washington.edu

Annual Review of Microbiology
|October 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Capillary electrophoresis Western blot using inkjet transfer to membrane.

Journal of chromatography. A·2022
Same author

Accurate detection of subclonal variants in paired diagnosis-relapse acute myeloid leukemia samples by next generation Duplex Sequencing.

Leukemia research·2022
Same author

PolyG-DS: An ultrasensitive polyguanine tract-profiling method to detect clonal expansions and trace cell lineage.

Proceedings of the National Academy of Sciences of the United States of America·2021
Same author

Fast Immunoassay for Microfluidic Western Blotting by Direct Deposition of Reagents onto Capture Membrane.

Analytical methods : advancing methods and applications·2020
Same author

Rare Mutations in Cancer Drug Resistance and Implications for Therapy.

Clinical pharmacology and therapeutics·2020
Same author

Extensive subclonal mutational diversity in human colorectal cancer and its significance.

Proceedings of the National Academy of Sciences of the United States of America·2019
Same journal

Circadian Control of Host-Microbiome Symbioses.

Annual review of microbiology·2026
Same journal

Host-Pathogen Interactions in Malaria: Invasion, Neutralization, and Evasion.

Annual review of microbiology·2026
Same journal

From an Interest in Molecules to a Fascination with Microbes.

Annual review of microbiology·2026
Same journal

Bacterial Physiology in the Context of Algal Partners.

Annual review of microbiology·2026
Same journal

Introduction.

Annual review of microbiology·2025
Same journal

Decoding Microbial Community Assembly: Insights on Vectors of Infectious Diseases.

Annual review of microbiology·2025
See all related articles

Increasing viral mutation rates with mutagenic nucleoside analogs offers a novel strategy against RNA viruses and retroviruses. This lethal mutagenesis approach can exceed the error threshold, proving effective in treating infections like HIV and hepatitis C.

Area of Science:

  • Virology
  • Molecular Biology
  • Genetics

Background:

  • Riboviruses and retroviruses exhibit exceptionally high mutation rates.
  • Exceeding a critical mutation rate, or error threshold, can compromise viral viability.
  • Mutagenic nucleoside analogs present a promising therapeutic avenue for viral infections.

Purpose of the Study:

  • To explore the concept of lethal mutagenesis as a treatment strategy for RNA viruses and retroviruses.
  • To review the viral dynamics of quasispecies formation under mutagenic pressure.
  • To assess the feasibility and efficacy of using mutagenic nucleoside analogs.

Main Methods:

  • Review of existing literature on viral mutation rates and lethal mutagenesis.
  • Analysis of viral quasispecies dynamics.

Related Experiment Videos

  • Examination of experimental data on mutagenic nucleoside analogs and their effects on viral infections.

    • Main Results:

    • Lethal mutagenesis has been demonstrated in vitro for HIV-infected cells.
    • Ribavirin's efficacy in treating hepatitis C is postulated to be due to lethal mutagenesis.
    • Mutagenic nucleoside analogs show potential for controlling viral replication by inducing high mutation rates.

    Conclusions:

    • Lethal mutagenesis is a viable strategy for combating RNA virus and retrovirus infections.
    • The selection of appropriate mutagenic nucleoside analogs is crucial for therapeutic success.
    • Further research into viral dynamics and analog efficacy can optimize this treatment approach.